Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protein phosphatase 3 catalytic subunit alpha, also known as PPP3CA or calcineurin A alpha, is a calcium-dependent, calmodulin-stimulated serine/threonine protein phosphatase. It plays an essential role in the transduction of intracellular Ca²⁺-mediated signals and is a key component of the calcineurin complex. It catalyzes the removal of phosphate groups from serine and threonine residues in proteins. Requires both calcium ions and calmodulin for activation. Involved in several cellular processes including calcineurin-NFAT signaling cascade and regulation of gene expression. Mutations or dysregulation are associated with several diseases.
Inhibition of phosphatase activity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein Phosphatase 3 Catalytic Subunit Alpha (PPP3CA).